News|Articles|October 20, 2026

Fall Clinical 2026 packed 4 days of data, debate, and hands-on guidance into Las Vegas, and the faculty were direct about what updates can help impact your practice. Dermatology Times heard from Joel Gelfand, MD, MSCE; Angela Fitch, MD; Raj Chovatiya, MD, PhD, MSCI; Aaron Farberg, MD; Christopher Bunick, MD, PhD; Jennifer Hsiao, MD; Ahmad Naim, MD; Todd Schlesinger, MD; Neal Bhatia, MD; Shannon Trotter, DO; Glynis Ablon, MD; and Iltefat Hamzavi, MD. Their takeaways span psoriasis to skin cancer, from an oral IL-23 receptor blocker holding clearance through 2 years to a nonsurgical option for superficial basal cell carcinoma, organized by topic below.